PARP Inhibition Restores Extrinsic Apoptotic Sensitivity in Glioblastoma

Georg Karpel‐Massler(Universität Ulm), Markus D. Siegelin(Columbia University Irving Medical Center)

PLoS ONE

December 22, 2014

10.1371/journal.pone.0114583

Cited by 42

Related Papers

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

|Cell|2022|216

HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models

|Journal of Clinical Investigation|2020|204

TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners <i>in vitro</i> and <i>in vivo</i>

|Oncotarget|2015|65

Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis <i>in vitro</i> and <i>in vivo</i>

|Oncotarget|2016|56

Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3 overcomes apoptotic resistance in glioblastoma <i>in vitro</i> and <i>in vivo</i>

|Oncotarget|2015|52